ZHANG Qing, CHI Hui-chang, YU Jie, et al. Clinical Study of Guben Yiliu Ⅱ Combined with Chemicals Arterial Perfusion for Advanced Hepatoma of 58 Cases[J]. Journal of Traditional Chinese Medicine2007, (3): 235-237.
ZHANG Qing, CHI Hui-chang, YU Jie, et al. Clinical Study of Guben Yiliu Ⅱ Combined with Chemicals Arterial Perfusion for Advanced Hepatoma of 58 Cases[J]. Journal of Traditional Chinese Medicine2007, (3): 235-237.DOI: 10.13288/j.11-2166/r.2007.03.019.
Objective To study the therapeutic effect of Guben Yiliu Ⅱ combined with chemicals arterial perfusion for advanced hepatoma.Methods Totally 112 cases of primary hepatic carcinoma(PHC)were randomly divided into 2 groups.Control group of 54 cases was treated with chemicals arterial perfusion
while Guben Yiliu Ⅱ was added to 58 cases in treatment group.Perfusion was conducted once every 3 or 4 weeks for at least 3 courses.Short-term efficacy
quality of life
one-year and two-year survival rates were observed.Results The steady rate
one-year survival rate and two-year survival rate of treatment group was 89.7%
68.9% and 51.7% respectively
higher than those in control group (P<0.05).The combined treatment could relieve adverse effect of chemotherapeutics
protect hepatic function and improve quality of life.Conclusion Guben Yiliu Ⅱ combined with chemicals arterial perfusion has attenuation and synergy for PHC.